Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Payables (2016 - 2025)

Biomerica's Payables history spans 15 years, with the latest figure at $740000.0 for Q4 2025.

  • For Q4 2025, Payables fell 12.74% year-over-year to $740000.0; the TTM value through Nov 2025 reached $740000.0, down 12.74%, while the annual FY2025 figure was $672000.0, 40.95% down from the prior year.
  • Payables for Q4 2025 was $740000.0 at Biomerica, up from $681000.0 in the prior quarter.
  • Across five years, Payables topped out at $2.6 million in Q1 2022 and bottomed at $387228.0 in Q1 2023.
  • The 5-year median for Payables is $748068.0 (2021), against an average of $889581.4.
  • The largest annual shift saw Payables surged 245.02% in 2022 before it tumbled 85.16% in 2023.
  • A 5-year view of Payables shows it stood at $1.6 million in 2021, then crashed by 57.61% to $670074.0 in 2022, then rose by 16.85% to $783000.0 in 2023, then increased by 8.3% to $848000.0 in 2024, then dropped by 12.74% to $740000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Payables are $740000.0 (Q4 2025), $681000.0 (Q3 2025), and $672000.0 (Q2 2025).